Danish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

chymotrypsin/betændelse

Linket gemmes på udklipsholderen
Side 1 fra 19 resultater

Substituted isocoumarins as serine protease inhibitors and anti-inflammatory agents

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a novel class of heterocyclic compounds useful for selectively inhibiting trypsin-like enzymes, selectively inhibiting chymotrypsin-like enzymes, selectively inhibiting elastase or for generally inhibiting serine

Isocoumarins with basic substituents as serine proteases inhibitors, anticoagulants and anti-inflammatory agents

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a novel class of heterocyclic compounds useful for selectively inhibiting trypsin-like enzymes, selectively inhibiting chymotrypsin-like enzymes, selectively inhibiting elastase or for generally inhibiting serine

Isocoumarins with basic substituents as serine proteases inhibitors, anticoagulants and anti-inflammatory agents

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to a novel class of heterocyclic compounds useful for selectively inhibiting trypsin-like enzymes, selectively inhibiting chymotrypsin-like enzymes, selectively inhibiting elastase or for generally inhibiting serine

Compounds for enzyme inhibition

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition. BACKGROUND OF THE INVENTION In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in

Compounds for enzyme inhibition

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition. BACKGROUND OF THE INVENTION In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in

Compounds for enzyme inhibition

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition. BACKGROUND OF THE INVENTION In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in

Compounds for enzyme inhibition

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition. BACKGROUND OF THE INVENTION In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in

Compounds for enzyme inhibition

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition. BACKGROUND OF THE INVENTION In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in

Compounds for proteasome enzyme inhibition

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition. BACKGROUND OF THE INVENTION In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in

Compounds for enzyme inhibition

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition. BACKGROUND OF THE INVENTION In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in

Compounds for enzyme inhibition

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition. BACKGROUND OF THE INVENTION In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in

Compounds for enzyme inhibition

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition. BACKGROUND OF THE INVENTION In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in

Compounds for enzyme inhibition

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods based on enzyme inhibition. BACKGROUND OF THE INVENTION In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in

Enzyme inhibition

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods deriving from enzyme inhibition. BACKGROUND In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in which proteins

Enzyme inhibition

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD This invention relates to compounds and methods for enzyme inhibition. In particular, the invention relates to therapeutic methods deriving from enzyme inhibition. BACKGROUND In eukaryotes, protein degradation is predominately mediated through the ubiquitin pathway in which proteins
Deltag i vores
facebook-side

Den mest komplette database med medicinske urter understøttet af videnskab

  • Arbejder på 55 sprog
  • Urtekurer, der understøttes af videnskab
  • Urtegenkendelse ved billede
  • Interaktivt GPS-kort - tag urter på stedet (kommer snart)
  • Læs videnskabelige publikationer relateret til din søgning
  • Søg medicinske urter efter deres virkninger
  • Organiser dine interesser og hold dig opdateret med nyhedsundersøgelser, kliniske forsøg og patenter

Skriv et symptom eller en sygdom, og læs om urter, der kan hjælpe, skriv en urt og se sygdomme og symptomer, den bruges mod.
* Al information er baseret på offentliggjort videnskabelig forskning

Google Play badgeApp Store badge